Hennepin Healthcare starts trials on antiviral drug showing promise with severe COVID-19 cases
![](https://www.hennepinhealthcare.org/wp-content/plugins/bb-plugin/img/pixel.png)
A drug that is showing some early success in treating severe cases of COVID-19 is now being studied in trials by Hennepin Healthcare. The Hennepin Healthcare Research Institute has launched two trials to study the safety of remdesivir.